Published in Int J Radiat Oncol Biol Phys on June 18, 2009
Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol (2011) 2.05
Dosimetric and radiobiological characterizations of prostate intensity-modulated radiotherapy and volumetric-modulated arc therapy: A single-institution review of ninety cases. J Med Phys (2016) 1.38
A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment. Int J Radiat Oncol Biol Phys (2012) 1.19
Early clinical experience of radiotherapy of prostate cancer with volumetric modulated arc therapy. Radiat Oncol (2010) 1.06
Comparison of prostate IMRT and VMAT biologically optimised treatment plans. Med Dosim (2010) 1.06
Impact of gantry rotation time on plan quality and dosimetric verification--volumetric modulated arc therapy (VMAT) vs. intensity modulated radiotherapy (IMRT). Strahlenther Onkol (2011) 1.00
Multicriteria VMAT optimization. Med Phys (2012) 0.98
Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy? Int J Radiat Oncol Biol Phys (2012) 0.98
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors. Radiat Meas (2012) 0.95
Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability. Ann Med Health Sci Res (2014) 0.94
A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol (2010) 0.93
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer. Phys Med Biol (2012) 0.91
Inverse planning for four-dimensional (4D) volumetric modulated arc therapy. Med Phys (2010) 0.90
RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study. Br J Radiol (2012) 0.88
A retrospective planning analysis comparing intensity modulated radiation therapy (IMRT) to volumetric modulated arc therapy (VMAT) using two optimization algorithms for the treatment of early-stage prostate cancer. J Med Radiat Sci (2013) 0.86
FusionArc optimization: a hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy. Med Phys (2013) 0.85
Four-dimensional CT-based evaluation of volumetric modulated arc therapy for abdominal lymph node metastasis from hepatocellular carcinoma. J Radiat Res (2012) 0.85
Searching standard parameters for volumetric modulated arc therapy (VMAT) of prostate cancer. Radiat Oncol (2012) 0.83
Application of volumetric modulated arc therapy (VMAT) in a dual-vendor environment. Radiat Oncol (2010) 0.83
Comparison of dosimetric variation between prostate IMRT and VMAT due to patient's weight loss: Patient and phantom study. Rep Pract Oncol Radiother (2013) 0.81
A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer. Br J Radiol (2013) 0.80
Comparing four volumetric modulated arc therapy beam arrangements for the treatment of early-stage prostate cancer. J Med Radiat Sci (2014) 0.80
Clinical utility of RapidArc™ radiotherapy technology. Cancer Manag Res (2015) 0.80
Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer. Radiat Oncol J (2016) 0.79
Optimal partial-arcs in VMAT treatment planning. Phys Med Biol (2012) 0.79
Utility of Smart Arc CDR for intensity-modulated radiation therapy for prostate cancer. J Radiat Res (2014) 0.79
Dose optimization with first-order total-variation minimization for dense angularly sampled and sparse intensity modulated radiation therapy (DASSIM-RT). Med Phys (2012) 0.79
Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity. J Radiat Res (2014) 0.78
Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment. Chin J Cancer (2013) 0.78
Exploring trade-offs between VMAT dose quality and delivery efficiency using a network optimization approach. Phys Med Biol (2012) 0.78
mARC vs. IMRT radiotherapy of the prostate with flat and flattening-filter-free beam energies. Radiat Oncol (2014) 0.77
Impact of margin size on the predicted risk of radiogenic second cancers following proton arc therapy and volumetric modulated arc therapy for prostate cancer. Phys Med Biol (2012) 0.77
Peripheral dose measurements in cervical cancer radiotherapy: a comparison of volumetric modulated arc therapy and step-and-shoot IMRT techniques. Radiat Oncol (2014) 0.77
Risk-adaptive volumetric modulated arc therapy using biological objective functions for subvolume boosting in radiotherapy. Comput Math Methods Med (2012) 0.77
A review on the use of grid-based Boltzmann equation solvers for dose calculation in external photon beam treatment planning. Biomed Res Int (2013) 0.76
An investigation of the dose distribution effect related with collimator angle in volumetric arc therapy of prostate cancer. J Med Phys (2016) 0.75
Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer. Med Dosim (2015) 0.75
Dose calculation for hypofractionated volumetric-modulated arc therapy: approximating continuous arc delivery and tongue-and-groove modeling. J Appl Clin Med Phys (2016) 0.75
The dosimetric significance of using 10 MV photons for volumetric modulated arc therapy for post-prostatectomy irradiation of the prostate bed. Radiol Oncol (2016) 0.75
Analysis of dose distribution in organs at risk in patients with prostate cancer treated with the intensity-modulated radiation therapy and arc technique. J Med Phys (2016) 0.75
Comparison of hybrid volumetric modulated arc therapy (VMAT) technique and double arc VMAT technique in the treatment of prostate cancer. Radiol Oncol (2015) 0.75
Volumetric modulated arc therapy for treatment of solid tumors: current insights. Onco Targets Ther (2017) 0.75
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys (2010) 3.73
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 3.61
Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol (2006) 3.12
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2002) 2.76
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys (2002) 2.65
Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer. Urology (2010) 2.57
Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol (2007) 2.56
Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer (2010) 2.42
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2012) 2.28
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer (2003) 2.24
Telomeric expression sites are highly conserved in Trypanosoma brucei. PLoS One (2008) 2.22
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol (2008) 2.08
Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2005) 2.04
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys (2005) 2.02
Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. Eur Urol (2011) 2.01
Equatorially dominated magnetic field change at the surface of Earth's core. Science (2003) 1.94
Intensity-modulated radiation therapy: supportive data for prostate cancer. Semin Radiat Oncol (2008) 1.91
The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol (2010) 1.87
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys (2008) 1.85
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res (2010) 1.68
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys (2003) 1.65
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.64
FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell (2010) 1.64
Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer (2005) 1.57
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.56
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys (2007) 1.54
Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Optimization of collimator trajectory in volumetric modulated arc therapy: development and evaluation for paraspinal SBRT. Int J Radiat Oncol Biol Phys (2010) 1.50
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
A novel small-angle neutron scattering detector geometry. J Appl Crystallogr (2013) 1.39
Estimating the volume of chronic pleural effusions using transesophageal echocardiography. J Cardiothorac Vasc Anesth (2011) 1.39
An autonomous implantable computer for neural recording and stimulation in unrestrained primates. J Neurosci Methods (2005) 1.38
Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys (2004) 1.37
Learning a novel myoelectric-controlled interface task. J Neurophysiol (2008) 1.36
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer (2006) 1.28
Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys (2006) 1.22
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med (2011) 1.22
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995. Int J Radiat Oncol Biol Phys (2005) 1.17
Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.14
Flexible cortical control of task-specific muscle synergies. J Neurosci (2012) 1.14
Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. Med Phys (2005) 1.13
Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys (2010) 1.13
Reanimating the arm and hand with intraspinal microstimulation. J Neural Eng (2011) 1.12
Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem (2010) 1.12
Intraoperative radiation therapy for breast cancer: technical notes. Breast J (2003) 1.10
IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys (2002) 1.09
The finished DNA sequence of human chromosome 12. Nature (2006) 1.08
Intensity-modulated radiotherapy. Cancer J (2002) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Slower Walking Speed Forecasts Increased Postoperative Morbidity and 1-Year Mortality Across Surgical Specialties. Ann Surg (2015) 1.07
Surgical Ward Round Quality and Impact on Variable Patient Outcomes. Ann Surg (2015) 1.07
Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry. J Oncol Pract (2013) 1.05
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Increased water retention in polymer electrolyte membranes at elevated temperatures assisted by capillary condensation. Nano Lett (2007) 1.04
Acquisition of MV-scatter-free kilovoltage CBCT images during RapidArc™ or VMAT. Radiother Oncol (2011) 1.04
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys (2006) 1.04
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol (2002) 1.04
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
Abstract and proportional myoelectric control for multi-fingered hand prostheses. Ann Biomed Eng (2013) 1.01
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2012) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol (2003) 1.00
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol (2002) 1.00
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
Intensity-modulated radiotherapy for lymphoma involving the mediastinum. Int J Radiat Oncol Biol Phys (2005) 0.99
A simplified intensity modulated radiation therapy technique for the breast. Med Phys (2002) 0.98
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction. Radiother Oncol (2010) 0.96
Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Choreographing couch and collimator in volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys (2011) 0.95
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol (2009) 0.95
The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res (2010) 0.95
Image-fusion of MR spectroscopic images for treatment planning of gliomas. Med Phys (2006) 0.94
Reduced-order parameter optimization for simplifying prostate IMRT planning. Phys Med Biol (2007) 0.94
Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development (2012) 0.94
Secondary prevention interventions for young drug users: a systematic review of the evidence. Adolescence (2005) 0.93